(Q51754017)
Statements
The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancer. (English)
1 reference
Christopher F Nicodemus
1 reference
Christina Chu
1 reference
Yvonne Collins
1 reference
Robert Edwards
1 reference
Alan Gordon
1 reference
William McGuire
1 reference
Christopher Schoonmaker
1 reference
Theresa Whiteside
1 reference
Lesley Mary Smith
1 reference
Michael Method
1 reference
1 January 2009
1 reference
32
1 reference
1
1 reference
54-65
1 reference